The Mass Balance Study of LP-168 in Healthy Subjects
Clinical trial NCT06126861 · COMPLETED
Trial details
- NCT number
- NCT06126861
- Sponsor
- Guangzhou Lupeng Pharmaceutical Company LTD.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-25
- Primary completion
- 2024-02-02
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.